Human papillomavirus type 18 infection in a female renal allograft recipient: a case report

Autor: Olga Jermakova, Rafail Rozental, Ieva Ziedina, Svetlana Chapenko, Dace Razeberga, Alina Sultanova, Baiba Lesina-Korne, Maksims Cistjakovs, Modra Murovska
Rok vydání: 2016
Předmět:
Adult
0301 basic medicine
Case Report
HPV-18
Renal allograft transplantation
Human Papillomavirus DNA Tests
03 medical and health sciences
Postoperative Complications
0302 clinical medicine
Focal segmental glomerulosclerosis
Pregnancy
medicine
Humans
RNA
Messenger

Human Papillomavirus DNA Test
Kidney transplantation
Vaginal Smears
Medicine(all)
Cervical cancer
Human papillomavirus 18
Glomerulosclerosis
Focal Segmental

business.industry
Papillomavirus Infections
Oncogene Proteins
Viral

General Medicine
Viral Load
medicine.disease
Kidney Transplantation
Abortion
Spontaneous

DNA-Binding Proteins
Transplantation
Immunosuppressive therapy
030104 developmental biology
030220 oncology & carcinogenesis
Immunology
Prednisolone
RNA
Viral

Female
Virus Activation
business
Viral load
Immunosuppressive Agents
medicine.drug
Zdroj: Journal of Medical Case Reports
ISSN: 1752-1947
Popis: Background Human papillomavirus type 18 is the second most common cause of cervical cancer and is found in 7 to 20 % of cases of cervical cancer. The oncogenic potential of high-risk human papillomavirus is associated with expression of early proteins E6 and E7. Due to long-term immunosuppressive therapy, renal transplant recipients have a higher risk of developing persistent human papillomavirus infection. Case presentation A 29-year-old white woman from Latvia with chronic focal segmental glomerulosclerosis received renal allograft transplantation and was prescribed immunosuppressive therapy with cyclosporine, prednisolone, and mycophenolate mofetil. Two weeks after renal transplantation, her cervical swab was positive for human papillomavirus consensus sequences. After 6 months, quantitative polymerase chain reaction showed a high viral load of 3,630,789 copies/105 cells of high-risk human papillomavirus type 18 and expression of E6 and E7 oncogenes in her cervical swab and urine sample. One year after renal transplantation, the viral load in her cervical swab increased significantly to 7,413,102 copies/105 cells. Messenger ribonucleic acid of human papillomavirus type 18 E6 and E7 oncogenes were also detected. Shortly after this, she had an unsuccessful pregnancy which resulted in a spontaneous abortion at 6/7 weeks. Two months after the abortion her viral load sharply decreased to 39 copies/105 cells. Oncogenes E6 and E7 messenger ribonucleic acid expression was not observed in this period. Conclusions This case report represents data which show that immunosuppressive therapy may increase the risk of developing persistent high-risk human papillomavirus infection with expression of E6 and E7 oncogenes in renal transplant recipients. However, even during this therapy the immune status of a recipient can improve and contribute to human papillomavirus viral load reduction. Spontaneous abortion can be considered a possible contributory factor in human papillomavirus clearance.
Databáze: OpenAIRE